93 related articles for article (PubMed ID: 3828945)
1. Circulating IgA immune complexes in head and neck cancer, nasopharyngeal carcinoma, lung cancer, and colon cancer.
Baseler MW; Maxim PE; Veltri RW
Cancer; 1987 May; 59(10):1727-31. PubMed ID: 3828945
[TBL] [Abstract][Full Text] [Related]
2. Single-assay combination of Epstein-Barr Virus (EBV) EBNA1- and viral capsid antigen-p18-derived synthetic peptides for measuring anti-EBV immunoglobulin G (IgG) and IgA antibody levels in sera from nasopharyngeal carcinoma patients: options for field screening.
Fachiroh J; Paramita DK; Hariwiyanto B; Harijadi A; Dahlia HL; Indrasari SR; Kusumo H; Zeng YS; Schouten T; Mubarika S; Middeldorp JM
J Clin Microbiol; 2006 Apr; 44(4):1459-67. PubMed ID: 16597877
[TBL] [Abstract][Full Text] [Related]
3. Composition of IgA immune complexes precipitated with polyethylene glycol. A model for isolation and analysis of immune complexes.
Imai H; Chen A; Wyatt RJ; Rifai A
J Immunol Methods; 1987 Nov; 103(2):239-45. PubMed ID: 3668260
[TBL] [Abstract][Full Text] [Related]
4. [Circulating immune complexes in malignant tumors].
Savina NP
Sov Med; 1989; (8):8-10. PubMed ID: 2814673
[TBL] [Abstract][Full Text] [Related]
5. The specific detection of IgA in immune complexes.
Kauffmann RH; Van Es LA; Daha MR
J Immunol Methods; 1981; 40(2):117-29. PubMed ID: 7019333
[TBL] [Abstract][Full Text] [Related]
6. Seroprevalence of IgA anti Epstein-Barr virus is high among family members of nasopharyngeal cancer patients and individuals presenting with chronic complaints in head and neck area.
Hutajulu SH; Fachiroh J; Argy G; Indrasari SR; Indrawati LPL; Paramita DK; Jati TBR; Middeldorp JM
PLoS One; 2017; 12(8):e0180683. PubMed ID: 28800616
[TBL] [Abstract][Full Text] [Related]
7. Circulating immune complexes in patients with nasopharyngeal carcinoma.
Wolf GT; Wolfe RA
Laryngoscope; 1990 Mar; 100(3):302-8. PubMed ID: 1689798
[TBL] [Abstract][Full Text] [Related]
8. Establishment of VCA and EBNA1 IgA-based combination by enzyme-linked immunosorbent assay as preferred screening method for nasopharyngeal carcinoma: a two-stage design with a preliminary performance study and a mass screening in southern China.
Liu Y; Huang Q; Liu W; Liu Q; Jia W; Chang E; Chen F; Liu Z; Guo X; Mo H; Chen J; Rao D; Ye W; Cao S; Hong M
Int J Cancer; 2012 Jul; 131(2):406-16. PubMed ID: 21866545
[TBL] [Abstract][Full Text] [Related]
9. Expression of EBV antibody EA-IgA, Rta-IgG and VCA-IgA and SA in serum and the implication of combined assay in nasopharyngeal carcinoma diagnosis.
Xia C; Zhu K; Zheng G
Int J Clin Exp Pathol; 2015; 8(12):16104-10. PubMed ID: 26884888
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of a semi-quantitative ELISA for IgA antibody against Epstein-Barr virus capsid antigen in the serological diagnosis of nasopharyngeal carcinoma.
Chen H; Chi P; Wang W; Li L; Luo Y; Fu J; Zhang L; Liu W
Int J Infect Dis; 2014 Aug; 25():110-5. PubMed ID: 24878579
[TBL] [Abstract][Full Text] [Related]
11. CEA-containing immune complexes in sera of patients with colorectal and breast cancer--analysis of complexed immunoglobulin classes.
Fuchs C; Krapf F; Kern P; Hoferichter S; Jäger W; Kalden JR
Cancer Immunol Immunother; 1988; 26(2):180-4. PubMed ID: 3282655
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of IgA specific antibodies to Epstein-Barr virus capsid and early antigens in nasopharyngeal carcinoma.
Puthavathana P; Kositanont U; Chongkolwatana C; Metheetrairut C; Chantarakul N; Nuntarakchaikul S; Wasi C
Asian Pac J Allergy Immunol; 1993 Jun; 11(1):39-43. PubMed ID: 8216557
[TBL] [Abstract][Full Text] [Related]
13. Serum anti-EBV IgA is inversely related to tumor infiltration by surface IgA positive lymphocytes in nasopharyngeal carcinoma.
Gunvén P; Klein G; Henle W; Henle G; Forsby N
Biomed Pharmacother; 1983; 37(1):41-4. PubMed ID: 6311307
[TBL] [Abstract][Full Text] [Related]
14. Detection of IgA against Epstein-Barr virus BZLF-1 replication activator (ZEBRA) in sera of nasopharyngeal carcinoma patients with a recombinant ZEBRA protein.
Shu CH; Tu TY; Lin LS; Ro LH; Lo MS; Huang CH; Chen KY; Liu WT
Zhonghua Yi Xue Za Zhi (Taipei); 1999 Jun; 62(6):350-5. PubMed ID: 10389292
[TBL] [Abstract][Full Text] [Related]
15. Novel Epstein-Barr virus immunoglobulin G-based approach for the specific detection of nasopharyngeal carcinoma.
Abdulamir AS; Hafidh RR; Abu Bakar F; Abbas K
Am J Otolaryngol; 2010; 31(6):410-7. PubMed ID: 20015794
[TBL] [Abstract][Full Text] [Related]
16. Rta-IgG as a biomarker for diagnosis and post treatment prognostic of nasopharyngeal carcinoma.
Xu XF; Lu RQ; Xiao R; Zhou L; Zhao XM; Hu XC; Gao X; Guo L
Cancer Biomark; 2016; 16(3):467-76. PubMed ID: 27062704
[TBL] [Abstract][Full Text] [Related]
17. Immune complexes in IgA nephropathy: presence of antibodies against diet antigens and delayed clearance of specific polymeric IgA immune complexes.
Sancho J; Egido J; Rivera F; Hernando L
Clin Exp Immunol; 1983 Oct; 54(1):194-202. PubMed ID: 6616968
[TBL] [Abstract][Full Text] [Related]
18. Soluble immune complexes and squamous cell carcinoma-related antigens in patients with head and neck cancer.
Yamanaka N; Himi T; Harabuchi Y; Hoki K; Kataura A
Cancer; 1988 Nov; 62(9):1932-8. PubMed ID: 3167806
[TBL] [Abstract][Full Text] [Related]
19. The reliability of IgA antibody to Epstein-Barr virus (EBV) capsid antigen as a test for the diagnosis of nasopharyngeal carcinoma (NPC).
Levine PH; Pearson GR; Armstrong M; Bengali Z; Berenberg J; Easton J; Goepfert H; Henle G; Henle W; Heffner D; Huang A; Hyams VJ; Lanier A; Neel HB; Pilch B; Pointek N; Taylor W; Terebelo H; Weiland L
Cancer Detect Prev; 1981; 4(1-4):307-12. PubMed ID: 6299561
[TBL] [Abstract][Full Text] [Related]
20. Experimental histoplasmosis in the mouse. Immunoglobulin class response, total immunoglobulin A levels, immune complex formation, and occurrence of antigen in serum and urine.
Sweet GH; Dulohery SM
Am Rev Respir Dis; 1989 Oct; 140(4):967-73. PubMed ID: 2508525
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
